Useful Therapeutic Markers of Atopic Dermatitis: Neurogenic Factors

Skin Research

Volumn 11, Issue , 2005, Pages 87-93

  Toyoda, Masahiko ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Atopic dermatitis; Nerve growth factor; Neuropeptides; Pruritus; Substance P

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; ATOPIC DERMATITIS; BLOOD ANALYSIS; BODY FLUID; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; SALIVA; URINALYSIS;

EID: 28844435036     PISSN: 13471813     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Gianetti A, Girolomoni G: Skin reactivity to neuropeptides in atopic dermatitis. Br J Dermatol 1989; 120: 681–688.
2. Coulson IH, Holden CA: Cutaneous reaction to substance P and histamine in atopic dermatitis. Br J Dermatol 1990; 122: 343–349.
3. Wallengren J, Ekman R, Moller H: Substance P and vasoactive intestinal peptide in bullous and inflammatory skin disease. Acta Derm Venereol 1986; 66: 23–28.
4. Anand P, Springall DR, Blank MA, Sellu D, Polak JM, Bloom SR: Neuropeptides in skin disease: Increased VIP in eczema and psoriasis but not axillary hyperhidrosis. Br J Dermatol 1991; 124: 547–549.
5. Gianetti A, Fantini F, Cimitan A, Pincelli C: Vasoactive intestinal polypeptide and substance P in the pathogenesis of atopic dermatitis. Acta Derm Venereol (Stockh) 1992; 176 (Supple.): 90–92.
6. Toyoda M, Nakamura M, Makino T, Hino T, Kagoura M, Morohashi M: Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 2002; 147: 71–79.
7. Rajka G, Langeland T: Grading of the severity of atopic dermatitis. Acta Derm Venereol(Stockh) 1989; 144 (Supple.): 1314.
8. Hanifin J. M., Thurston M., Omoto M., Cherill R., Tofte S. J., Graeber M., and the EASI Evaluator Group: The eczema area and severity index(EASI): Assessment of reliability in atopic dermatitis. Exp. Dermatol 2001; 10: 11–18.
9. European Task Force on Atopic Dermatitis: Severity scoring of atopic dermatitis: The SCORAD index. Dermatology 1993; 186: 23–31.
10. Dicon E, Masson C, Jabbour W, Nerviere V: Increased frequency of NGF in sera of eheumatoid arthritis and systemic lupus erythematosus patients. Neuroreport 1993; 5: 321–324.
11. Matucci-Cerinic M, Giacomelli R, Pignone A et al: Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma). Ann Rheum Dis 2001; 60: 487–494.
12. Nakamura M, Toyoda M, Morohashi M: Pruritogenic mediators in psoriasis vulgaris: Comparative evaluation of itch-associated factors. Br J Dermatol 2003; 149: 718–730.
13. Kirschbaum C, Hellhammer DH: Salivary cortisol in psychobiological research: An overview. Neuropsychobiology 1989; 55: 180–269.